AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Semaglutide in Kenya
22 products registered with PPB — 22 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Wegovy® 2.4mg, 3ml FlexTouch® Solution For Injection In Pre-Filled Pen | H2026/CTD13328/28405 | Novo Nordisk A/S | active | 26 Jun 2031 |
| Wegovy® 1.7 mg, 3 ml FlexTouch® Solution For Injection In Pre-Filled Pen | H2026/CTD13329/28396 | Novo Nordisk A/S | active | 26 Jun 2031 |
| Wegovy® 0.5 mg, 3 ml FlexTouch® Solution For Injection In Pre-Filled Pen | H2026/CTD13326/28391 | Novo Nordisk A/S | active | 26 Jun 2031 |
| Ozempic® 0.5 mg solution for injection in 1.5ml… Solution For Injection In Pre-Filled Pen | H2026/CTD13423/29249 | Novo Nordisk A/S | active | 12 May 2031 |
| Ozempic® 0.5 mg solution for injection in 3ml… Solution For Injection In Pre-Filled Pen | H2026/CTD13424/29254 | Novo Nordisk A/S | active | 12 May 2031 |
| Ozempic® 0.25 mg solution for injection in… Solution For Injection In Pre-Filled Pen | H2026/CTD13425/29255 | Novo Nordisk A/S | active | 12 May 2031 |
| Ozempic® 1 mg solution for injection in… Solution For Injection In Pre-Filled Pen | H2026/CTD13426/29256 | Novo Nordisk A/S | active | 12 May 2031 |
| TRUGLYX 0.25 Injection | H2026/CTD13300/28418 | HETERO LABS LIMITED | active | 12 May 2031 |
| Wegovy® 0.5 mg, 1.5 ml FlexTouch® Solution For Injection In Pre-Filled Pen | H2026/CTD13327/28403 | Novo Nordisk A/S | active | 12 May 2031 |
| Wegovy® 1 mg, 3 ml FlexTouch® Solution For Injection In Pre-Filled Pen | H2026/CTD13330/28394 | Novo Nordisk A/S | active | 12 May 2031 |
| Wegovy® 0.25 mg, 1.5 ml FlexTouch® Solution For Injection In Pre-Filled Pen | H2026/CTD13325/28404 | Novo Nordisk A/S | active | 12 May 2031 |
| TRUGLYX 1 Injection | H2026/CTD13298/28416 | HETERO LABS LIMITED | active | 29 Apr 2031 |
| TRUGLYX 0.5 Injection | H2026/CTD13299/28415 | HETERO LABS LIMITED | active | 20 Apr 2031 |
| Sema Q 1.7mg/0.75ml Prefilled Syringe Injection Solution For Injection In Pre-Filled Syringe | H2025/CTD12264/26829 | Q PHARMA DMCC | active | 14 Jul 2030 |
| Sema Q 2.4 mg/0.75ml Prefilled Syringe Injection Solution For Injection In Pre-Filled Syringe | H2025/CTD12265/26830 | Q PHARMA DMCC | active | 8 Jul 2030 |
| Sema Q 1 mg/0.5 ml Prefilled Syringe Injection Solution For Injection | H2025/CTD12146/26809 | Q PHARMA DMCC | active | 8 Jul 2030 |
| Sema Q 0.25 Injection Solution For Injection | H2025/CTD11507/25178 | Q PHARMA DMCC | active | 20 Jan 2030 |
| Sema Q 0.5mg Injection Solution For Injection | H2025/CTD11508/25179 | Q PHARMA DMCC | active | 20 Jan 2030 |
| GLUCOSET 14MG TABLETS Tablet | H2024/CTD11189/24970 | COSMOS LIMITED | active | 16 Sept 2029 |
| GLUCOSET 7MG TABLETS Tablet | H2024/CTD11190/24967 | COSMOS LIMITED | active | 31 Jul 2029 |
| GLUCOSET 3MG TABLETS Tablet | H2024/CTD11191/24964 | COSMOS LIMITED | active | 31 Jul 2029 |
| Reglutide Solution For Injection Injection | H2024/CTD10866/24476 | Beximco Pharmaceuticals Limited | active | 4 Mar 2029 |
Semaglutide — PPB Registration Details
PPB (Kenya) has 22 registered products containing Semaglutide, of which 22 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Semaglutide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.